Current evidence strongly suggests the increase of Apo D expression in NDs such as Schizophrenia (SZ), Bipolar Disorders (BPD), Major Depressive Disorders (MDD), or Autism Spectrum Disorder (ASD), a group of diseases that shares some cardinal pathological features including oxidative stress, excitotoxicity, myelin dysfunction, cholesterol imbalance, and apoptosis, and where it seems to play a fundamental role as a neuroprotective protein. Here, APOD is linked to schizophrenia.